De novo mutation in POLG leads to haplotype insufficiency and Alpers syndrome

Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institute of Health, Research Triangle Park, NC 27709, USA.
Mitochondrion (Impact Factor: 3.25). 06/2009; 9(5):340-5. DOI: 10.1016/j.mito.2009.05.002
Source: PubMed


Mutations in POLG are a major contributor to pediatric and adult mitochondrial diseases. However, the consequences of many POLG mutations are not well understood. We investigated the molecular cause of Alpers syndome in a patient harboring the POLG mutations A467T in trans with c.2157+5_+6 gc-->ag in intron 12. Analysis of transcripts arising from the c.2157+5_+6 gc-->ag allele revealed alternative splicing with an insertion of 30 intronic nucleotides leading to a premature termination codon. These transcripts were subsequently removed through nonsense-mediated decay, leading to haplotype insufficiency due to expression of the A467T allele and decreased expression of the c.2157+5_+6 gc-->ag allele, which is likely responsible for the Alpers syndrome phenotype.

Download full-text


Available from: William C Copeland, Dec 20, 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondriale Erkrankungen sind – wie auch die übrigen Artikel dieses Schwerpunkthefts verdeutlichen – ein weites Feld in der klinischen Genetik. Aufgrund des bunten klinischen Bildes sowohl bei Kindern als auch bei Erwachsenen ergeben sich relativ häufig Konstellationen, in denen auch eine mitochondriale Erkrankung in das differenzialdiagnostische Spektrum mit einbezogen wird. In der genetischen Beratung stellt dies eine besondere Herausforderung dar, da unter dieser Verdachtsdiagnose grundsätzlich alle Erbgänge, inklusive einer maternalen Vererbung, möglich sind und gleichzeitig eine zielgerichtete Diagnostik zum molekulargenetischen Beleg oder auch Ausschluss der Diagnose durch die außerordentliche genetische Heterogenität erschwert ist. Im Folgenden erläutern wir ein rationales Vorgehen in der molekulargenetischen Diagnostik und besondere Aspekte der genetischen Beratung.
    No preview · Article · Sep 2012 · Medizinische Genetik
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mitochondrial disorders result from primary defects in the mitochondrial DNA (mtDNA) or from defects in nuclear genes which cause disease by affecting the mtDNA. POLG1 is a nuclear gene which encodes for the catalytic subunit of the mtDNA polymerase gamma, essential for mtDNA replication. Less than a decade ago, POLG1 mutations were discovered in patients with progressive external ophthalmoplegia. Since then, it has emerged that POLG1 mutations can result in a spectrum of clinical manifestations, resulting in autosomal recessive or dominant mitochondrial diseases. Here we summarize the common clinical phenotypes associated with POLG1 mutations. Alpers syndrome, progressive external ophthalmoplegia with or without limb myopathy, ataxia-neuropathy syndrome, and epilepsy are frequent clinical manifestations of the POLG1-related disease. Childhood progressive encephalopathy, Parkinsonism, stroke-like events, and isolated exercise intolerance can occur in association with POLG1 mutations. Muscle biopsy can show signs of mitochondrial dysfunction by histologic and biochemical studies or it can be unrevealing. mtDNA analysis of affected tissues can reveal depletion, multiple deletions or point mutations, but it can be occasionally noninformative by routine analysis. : POLG1 mutations result in extremely heterogenous phenotypes which often have overlapping clinical findings, making it difficult to categorize patients into syndromes. The lack of signs of mitochondrial dysfunction in the muscle biopsy does not exclude a POLG1-related disease. Analysis of mtDNA of clinically affected tissues is often informative, but not always. Molecular analysis of POLG1 is essential when POLG1-related disease is suspected. Sodium valproate should be avoided because of the risk of liver failure.
    No preview · Article · Mar 2010 · The Neurologist
  • [Show abstract] [Hide abstract]
    ABSTRACT: The POLG genes were sequenced in two unrelated patients presenting with Alpers syndrome. The novel c.3626_3629dupGATA and the c.3643+2T>C alleles were associated in trans with p.A467T and p.[W748S;E1143G], respectively. POLG transcripts from skin fibroblasts showed complete exon 22 skipping for patient 2, but surprisingly partial exon 22 skipping from the c.3626_3629dupGATA for patient 1. The creation of a putative exonic splicing silencer could be responsible for the splicing anomaly observed in patient 1. Both c.3643+2T>C and c.3626_3629dupGATA create a premature termination codon and a low polymerase γ activity in skin fibroblasts is responsible for the severe phenotype in these patients.
    No preview · Article · Jan 2011 · Mitochondrion
Show more